An early alternative to medical therapy that provides rapid relief and recovery of BPH symptoms.1,3,4 The UroLift® System is minimally invasive and offers better symptom relief than medication4 with a lower risk profile than TURP.2
The UroLift System is supported by extensive clinical experience in controlled studies; large multi-centre studies; small studies; retrospective registry and peer-reviewed publications.
View the spectrum of UroLift System clinical results and data:
Download the UroLift System Instructions for Use document to learn more about:
Source Information
Indicated for the treatment of symptoms of an enlarged prostate up to 100cc in men 45 years or older. As with any medical procedure, individual results may vary. Most common side effects are temporary and include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence (Roehrborn, J Urology 2013). Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention. Consult the Instructions for Use (IFU) for more information.
Contraindicated in men with current gross hematuria, urinary tract infection, urinary incontinence, urethral conditions that prevent device insertion, or a prostate volume greater than 100cc.
Teleflex, the Teleflex logo, UroLift, the UroLift logo, BPH Advisor, MyBPHReport, and UroLift ATC are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the US and/or other countries.
IDA Business and Technology Park
Dublin Road, Athlone
Co Westmeath
© 2025 Teleflex Inc. All rights reserved. | Terms of Use | Internet Privacy Policy | Patient Safety | Imprint | Compliance
MCI-2022-0109